Moderna reports fiscal Q2 2026 results: revenue $145.0M, up 2% from a year earlier

Moderna filed a Form 8-K with the SEC on Jul 31, 2026, 7:03 AM ET, reporting an event dated Jul 31, 2026. It covers Item 2.02 (Results of Operations and Financial Condition); Item 9.01 (Financial Statements and Exhibits). The results cover fiscal Q2 2026 (quarter ended Jun 30, 2026); figures below are from the company's XBRL financial data filed with the SEC.

• Revenue: $145.0M (+2.1% from $142.0M a year earlier)
• Operating income: −$815.0M (vs −$907.0M a year earlier)
• Net income: −$782.0M (vs −$825.0M a year earlier)
• Diluted EPS: $-1.97 (vs $-2.13 a year earlier)
• Form 8-K accepted by EDGAR Jul 31, 2026, 7:03 AM ET
• Accession number 0001682852-26-000147

SEC filing 8-K · accession 0001682852-26-000147 · sec.gov ↗